Trump Cancer Research Chief Retains Interim Role as Others Leave

The Biden administration has held over the National Cancer Institute Director Ned Sharpless, whom President Donald Trump installed in 2017.

Sharpless also served as acting FDA commissioner for about six months before Trump nominated Steve Hahn to lead the agency. Hahn stepped down from that role, as expected, on Jan. 20.

Sharpless is unique among Trump’s top medical officials in retaining his spot in the new administration, even in an interim capacity. The NCI confirmed to Bloomberg Law he has not been asked to step down, in contrast to President Joe Biden’s request to Jerome Adams, Trump’s surgeon general, ...